Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and Aspirin in Recurrent Prostate Cancer (PRIMA)
NCT02420652Phase 2Terminated
- Sponsor
- Rutgers University
- Start
- Jun 2015
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs), aspirin in prostate cancer (PCa), sponsored by Rutgers University. Started Jun 2015; status: terminated.
02
Drugs
liquid metformin (Aspargo Labs)aspirin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02420652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02420652.